Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions

doi:10.3969/j.issn.1000-6621.2020.09.007

Abstract

Abstract:

Objective To learn the understanding on the major contents of Standard WS 196—2017 Classification of tuberculosis and WS 288—2017 Diagnosis for pulmonary tuberculosis among parctitioners in the TB control, or medical staff in designated medical institutions and/or TB control staff in the center for disease control and prevention at the survey sites, and propose measures to further implement the new standards.Methods This was a cross-sectional study, including 5 provinces (autonomous region) selected according to geographical distribution and previous work on TB control, including 4 prefectures (cities), 9 counties (districts). A questionnaire was used to investigate staff working on management and clinical diagnosis in designated medical institutions and center for disease control and prevention. The main content of the questionnaire was about technical updates on the two new standards, involving a total of 10 questions related to core information. Totally 325 questionnaires were distributed, 325 were retrieved. Collected data were statistically analyzed and verified using χ². P<0.05 was considered statistically significant difference.Results The results showed that the total awareness rate of staff in center for disease control and prevention (87.8%, 202/230) and doctors in designated medical institutions (85.1%, 1455/1710) were higher than other personnel (76.3%, 1000/1310), and the difference was statistically significant (χ² value were 15.078, 37.357 respectively; All P value were 0.000 respectively). The total awareness rate of all the information was 81.8% (2657/3250), of which the awareness rate of the 10th piece “Which part of the tuberculosis lesions in the new diagnostic criteria need to be registered and reported in accordance with the principles of tuberculosis management” was the highest, at 93.5% (304/325), while awareness rate of the 6th piece “How to diagnose non-active tuberculosis” was the lowest, at 73.2% (238/325).Conclusion This study showed that staff in 13 designated medical institutions and center for disease control and prevention did not fully understand these two new standards. In order to effectively control TB epidemic in China, it is essential to strengthen the effective promotion and implementation of the new standards.

Key words: Tuberculosis, Updated standard, Knowledge, Questionnaires, Medical staff, Outcome assessment (health care), Data interpretation, statistical

MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925. doi: 10.3969/j.issn.1000-6621.2020.09.007

Figures/Tables 2

References 11

[1]	姜影, 孙浩, 李敏. 2017年北京市石景山区公众结核病防治核心信息知晓率调查. 首都公共卫生, 2019,13(4):205-208.
[2]	World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
[3]	中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类. 2017-11-09.
[4]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
[5]	中华人民共和国卫生部. 结核病防治管理办法. 卫生部令第92号. 2013-02-20.
[6]	中华人民共和国国务院办公厅. “十三五”全国结核病防治规划. 国办发〔2017〕16号. 2017-02-16.
[7]	中国疾病预防控制中心结核病预防控制中心. 2018年中国结核病监测报告. 北京: 中国疾病预防控制中心结核病预防控制中心, 2019.
[8]	周林, 刘二勇. 结核病诊断标准解读. 寄生虫病与感染性疾病, 2019,17(1):7-9.
[9]	马艳, 成诗明, 周林, 等. 初治涂阴肺结核胸片复读结果与诊断质量多因素分析. 中国防痨杂志, 2011,33(11):707-712.
[10]	周林, 刘二勇, 陈明亭, 等. 认真执行卫生行业新标准努力提升结核病防控质量. 中国防痨杂志, 2018,40(3):231-233. doi: 10.3969/j.issn.1000-6621.2018.03.002.
[11]	高孟秋, 黄艳伶. 分层教学法在结核病培训工作中的应用. 中国健康教育, 2015,31(10):1000-1001. doi: 10.16168/j.cnki.issn.1002-9982.2015.10.025.

问卷条目	回答正确(名)	知晓率(%)
1. 《WS 196—2017 肺结核分类》中对肺结核范畴如何界定?	243	74.8
2. 《WS 196—2017 肺结核分类》按照结核病发病进程将结核病分为哪几类?	259	79.7
3. 目前对结核分枝杆菌潜伏感染者常用的检查方法有哪些?	244	75.1
4. 结核菌素皮肤试验强阳性的判定标准?	260	80.0
5. 哪些人群是结核分枝杆菌潜伏感染者筛查的重点人群?	276	84.9
6. 非活动性肺结核如何判定?	238	73.2
7. 病原学检查方法有哪些?	301	92.6
8. 肺结核确诊依据是什么?	265	81.5
9. 结核性胸膜炎临床诊断病例的依据有哪些?	267	82.2
10. 按照《WS 288—2017 肺结核诊断》标准,以下哪些部位的结核病变需要执行肺结核管理原则的登记和报告?	304	93.5
合计	2657	81.8

问卷条目	疾控人员(23名)		医生(171名)		管理人员(131名)		χ²值	P值
问卷条目	知晓 (名)	知晓率 (%)	知晓 (名)	知晓率 (%)	知晓 (名)	知晓率 (%)	χ²值	P值
1. 《WS 196—2017 肺结核分类》标准中对肺结核范畴如何界定?	18	78.3	137	80.1	88	67.2	6.745	0.034
2. 《WS 196—2017 肺结核分类》标准中按照结核病发病进程将结核病分为哪几类?	20	87.0	138	80.7	101	77.1	1.402	0.496
3. 目前对结核分枝杆菌潜伏感染者常用的检查方法有哪些?	18	78.3	139	81.3	87	66.4	8.904	0.012
4. 结核菌素皮肤试验强阳性的判定标准?	21	91.3	145	84.8	94	71.8	9.859	0.007
5. 哪些人群是结核分枝杆菌潜伏感染者筛查的重点人群?	22	95.7	150	87.7	104	79.4	6.245	0.044
6. 非活动性肺结核如何判定?	19	82.6	137	80.1	82	62.6	12.727	0.002
7. 病原学检查方法有哪些?	22	95.7	158	92.4	121	92.4	0.333	0.846
8. 肺结核确诊依据是什么?	20	87.0	140	81.9	105	80.2	0.628	0.730
9. 结核性胸膜炎临床诊断病例的依据有哪些?	20	87.0	149	87.1	98	74.8	8.075	0.018
10. 按照《WS 288—2017 肺结核诊断》标准,以下哪些部位的结核病变需要执行肺结核管理原则的登记和报告?	22	95.7	162	94.7	120	91.6	1.388	0.499
合计	202	87.8	1455	85.1	1000	76.3	44.205	<0.0001

[1]	LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
[2]	Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of fixed-dose combination formulations [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893.
[3]	JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902.
[4]	ZHANG Can-you, XIA Hui, CHENG Jun. Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
[5]	ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915.
[6]	LIU Er-yong, WANG Qian, ZHOU Lin, ZHANG Guo-qin, ZHANG Xiu-lei, MA Yong-cheng, YANG Shu-min, WANG Cui, MENG Qing-lin, CHEN Ming-ting, LIN Ming-gui, TU De-hua.. Analysis of diagnostic quality of pulmonary tuberculosis with negative etiology in some areas of China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 916-920.
[7]	WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia.. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930.
[8]	LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936.
[9]	LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941.
[10]	SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947.
[11]	DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng.. Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955.
[12]	DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961.
[13]	MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
[14]	NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei. Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980.
[15]	ZHANG Li-juan, TAO Xiao, XIA Li-li, WEI Fen-fen, ZHENG Qi. Value of clinical pathway table of enhanced recovery cluster nursing in patients with spinal tuberculosis during perioperative period [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 981-986.